Erratum to: Opportunities and obstacles to the development of nanopharmaceuticals for human use

Erratum to: Opportunities and obstacles to the development of nanopharmaceuticals for human use

After publication of this article [1], the authors clarify that Nasser Nassiri Koopaei was affiliated to "Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran" at the time the research was carried out.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Daru 2016-11, Vol.24 (1), p.25, Article 25
Hauptverfasser: Koopaei, Nasser Nassiri, Abdollahi, Mohammad
Format: Artikel
Sprache:eng
Schlagworte:
Biomedical and Life Sciences
Biomedicine
Erratum
Medicinal Chemistry
Pharmaceutical Sciences/Technology
Pharmacology/Toxicology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 25
container_title Daru
container_volume 24
creator Koopaei, Nasser Nassiri
Abdollahi, Mohammad
description After publication of this article [1], the authors clarify that Nasser Nassiri Koopaei was affiliated to "Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran" at the time the research was carried out.
doi_str_mv 10.1186/s40199-016-0164-7
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5105287</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A469802709</galeid><sourcerecordid>A469802709</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4137-3216c9c2743b0641b47ab7e7d41416290620f2b6fb9c26004fe72c44583d11a3</originalsourceid><addsrcrecordid>eNp1kl1rHSEQhiW0JGnaH9CbIhRyt6lfq24vCiGkHxDITe7FdfWsYVe36gb67-vhJGEPtMigzjzzMjMMAB8xusJY8i-ZIdx1DcJ8b6wRJ-CcICQbQih-s3mfgXc5PyJEJePkFJwRISmRWJ4DdZuSLusMS_wK75clprIGX7zNUIcBxj4Xbab6KxGW0cLBPtkpLrMNBUYHgw5xGXWatbFr8UZPGbqY4LjOOsA12_fgratO--H5vgAP328fbn42d_c_ft1c3zWGYSoaSjA3nSGC0R5xhnsmdC-sGBhmmJMOcYIc6bnrK8QRYs4KYhhrJR0w1vQCfDvILms_28HU8pKe1JL8rNMfFbVXx5HgR7WLT6rFqCVSVIHPzwIp_l5tLuoxrinUkhWWrG2RRHRD7fRklQ8uVjEz-2zUNeOdRESgrlJX_6DqGezsTQzW-eo_SrjcJIxWT2XMcaoDjSEfg_gAmhRzTta9doiR2q-EOqyEquuwN6b2NX_ajuY142UHKkAOQK6hsLNp0_p_Vf8CRH2_3A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1845508037</pqid></control><display><type>article</type><title>Erratum to: Opportunities and obstacles to the development of nanopharmaceuticals for human use</title><source>Springer Nature - Complete Springer Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Koopaei, Nasser Nassiri ; Abdollahi, Mohammad</creator><creatorcontrib>Koopaei, Nasser Nassiri ; Abdollahi, Mohammad</creatorcontrib><description>After publication of this article [1], the authors clarify that Nasser Nassiri Koopaei was affiliated to "Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran" at the time the research was carried out.</description><identifier>ISSN: 2008-2231</identifier><identifier>ISSN: 1560-8115</identifier><identifier>EISSN: 2008-2231</identifier><identifier>DOI: 10.1186/s40199-016-0164-7</identifier><identifier>PMID: 27832818</identifier><language>eng</language><publisher>London: BioMed Central</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Erratum ; Medicinal Chemistry ; Pharmaceutical Sciences/Technology ; Pharmacology/Toxicology</subject><ispartof>Daru, 2016-11, Vol.24 (1), p.25, Article 25</ispartof><rights>The Author(s). 2016</rights><rights>COPYRIGHT 2016 BioMed Central Ltd.</rights><rights>Copyright BioMed Central 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4137-3216c9c2743b0641b47ab7e7d41416290620f2b6fb9c26004fe72c44583d11a3</citedby><cites>FETCH-LOGICAL-c4137-3216c9c2743b0641b47ab7e7d41416290620f2b6fb9c26004fe72c44583d11a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105287/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105287/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,41464,42533,51294,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27832818$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koopaei, Nasser Nassiri</creatorcontrib><creatorcontrib>Abdollahi, Mohammad</creatorcontrib><title>Erratum to: Opportunities and obstacles to the development of nanopharmaceuticals for human use</title><title>Daru</title><addtitle>DARU J Pharm Sci</addtitle><addtitle>Daru</addtitle><description>After publication of this article [1], the authors clarify that Nasser Nassiri Koopaei was affiliated to "Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran" at the time the research was carried out.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Erratum</subject><subject>Medicinal Chemistry</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Pharmacology/Toxicology</subject><issn>2008-2231</issn><issn>1560-8115</issn><issn>2008-2231</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kl1rHSEQhiW0JGnaH9CbIhRyt6lfq24vCiGkHxDITe7FdfWsYVe36gb67-vhJGEPtMigzjzzMjMMAB8xusJY8i-ZIdx1DcJ8b6wRJ-CcICQbQih-s3mfgXc5PyJEJePkFJwRISmRWJ4DdZuSLusMS_wK75clprIGX7zNUIcBxj4Xbab6KxGW0cLBPtkpLrMNBUYHgw5xGXWatbFr8UZPGbqY4LjOOsA12_fgratO--H5vgAP328fbn42d_c_ft1c3zWGYSoaSjA3nSGC0R5xhnsmdC-sGBhmmJMOcYIc6bnrK8QRYs4KYhhrJR0w1vQCfDvILms_28HU8pKe1JL8rNMfFbVXx5HgR7WLT6rFqCVSVIHPzwIp_l5tLuoxrinUkhWWrG2RRHRD7fRklQ8uVjEz-2zUNeOdRESgrlJX_6DqGezsTQzW-eo_SrjcJIxWT2XMcaoDjSEfg_gAmhRzTta9doiR2q-EOqyEquuwN6b2NX_ajuY142UHKkAOQK6hsLNp0_p_Vf8CRH2_3A</recordid><startdate>20161110</startdate><enddate>20161110</enddate><creator>Koopaei, Nasser Nassiri</creator><creator>Abdollahi, Mohammad</creator><general>BioMed Central</general><general>BioMed Central Ltd</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PADUT</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20161110</creationdate><title>Erratum to: Opportunities and obstacles to the development of nanopharmaceuticals for human use</title><author>Koopaei, Nasser Nassiri ; Abdollahi, Mohammad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4137-3216c9c2743b0641b47ab7e7d41416290620f2b6fb9c26004fe72c44583d11a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Erratum</topic><topic>Medicinal Chemistry</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Pharmacology/Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koopaei, Nasser Nassiri</creatorcontrib><creatorcontrib>Abdollahi, Mohammad</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Research Library China</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Daru</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koopaei, Nasser Nassiri</au><au>Abdollahi, Mohammad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Erratum to: Opportunities and obstacles to the development of nanopharmaceuticals for human use</atitle><jtitle>Daru</jtitle><stitle>DARU J Pharm Sci</stitle><addtitle>Daru</addtitle><date>2016-11-10</date><risdate>2016</risdate><volume>24</volume><issue>1</issue><spage>25</spage><pages>25-</pages><artnum>25</artnum><issn>2008-2231</issn><issn>1560-8115</issn><eissn>2008-2231</eissn><abstract>After publication of this article [1], the authors clarify that Nasser Nassiri Koopaei was affiliated to "Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran" at the time the research was carried out.</abstract><cop>London</cop><pub>BioMed Central</pub><pmid>27832818</pmid><doi>10.1186/s40199-016-0164-7</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2008-2231
ispartof Daru, 2016-11, Vol.24 (1), p.25, Article 25
issn 2008-2231
1560-8115
2008-2231
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5105287
source Springer Nature - Complete Springer Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects Biomedical and Life Sciences
Biomedicine
Erratum
Medicinal Chemistry
Pharmaceutical Sciences/Technology
Pharmacology/Toxicology
title Erratum to: Opportunities and obstacles to the development of nanopharmaceuticals for human use
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T10%3A45%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Erratum%20to:%20Opportunities%20and%20obstacles%20to%20the%20development%20of%20nanopharmaceuticals%20for%20human%20use&rft.jtitle=Daru&rft.au=Koopaei,%20Nasser%20Nassiri&rft.date=2016-11-10&rft.volume=24&rft.issue=1&rft.spage=25&rft.pages=25-&rft.artnum=25&rft.issn=2008-2231&rft.eissn=2008-2231&rft_id=info:doi/10.1186/s40199-016-0164-7&rft_dat=%3Cgale_pubme%3EA469802709%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1845508037&rft_id=info:pmid/27832818&rft_galeid=A469802709&rfr_iscdi=true